Hematologic cancers can be classified into three categories: leukemia, lymphoma, and multiple myeloma. Developing quality improvement programs aimed at reducing health care disparities and improving the standard of care received by patients with hematologic cancers are key priorities in ACCC’s educational portfolio.

2017年7月27日 · Genomic analysis has greatly influenced the diagnosis and clinical management of patients affected by diverse forms of hematologic malignancies. Here, we review how genetic alterations define subclasses of patients with acute leukemias, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPNs), non-Hodgkin lymphomas, and classical ...

2023年5月17日 · Hematologic malignancies are among the most common cancers, and understanding their incidence and death is crucial for targeting prevention, clinical practice improvement, and...

Blood cancer, also called hematological cancer, occurs when abnormal cells in the blood grow out of control. The abnormal cells can crowd out normal blood cells, which have important functions in the body: Red blood cells help carry oxygen throughout the body. White blood cells help fight infections. Platelets help blood clot.

Hematologic malignancies are a diverse group of cancers derived from the cells of hematopoietic tissue, including leukemia, multiple myeloma, lymphoma, myelodysplastic syndrome and myeloproliferative disease.

2018年6月19日 · ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukaemia, Diffuse large B cell lymphoma, Elderly patients with malignant lymphoma, Extranodal diffuse large B …

2023年8月18日 · Hematologic malignancies refer to malignant diseases originating from the lymphohematopoietic system and may involve all systems and organs throughout the body. Hematologic malignancies mainly...

2023年11月2日 · Understanding the future trends in the incidence, mortality, and disability-adjusted life years (DALYs) associated with hematological malignancies is crucial for effective health care planning and resource allocation.

2022年3月11日 · Hematologic malignancies are commonly known as blood cancer. The condition includes a wide range of myelomas, lymphomas, and leukemias that originate in the cells of the immune and lymphatic system of the body. The history of hematologic malignancies dates back to the year 1832 when Thomas Hodgkin characterized a type of malignant lymphoma.

Radiation therapy plays a critical role in the management of a wide range of hematologic malignancies. The optimal radiation dose and target volume, and safe and effective ways of integrating radiation with systemic agents, vary depending on the histologic subtypes, stage at presentation, patient pe …